Indivior shares plunge after US move and profit warning Pharma Indivior lowered its annual adjusted operating profit forecast and shares in the company plunged.
GSK to pay Curevac £1.2bn for full rights to develop and commercialise mRNA vaccines pharma GSK will assume full control of developing and manufacturing the candidate vaccines and will have worldwide rights to commercialise them.
Alliance Pharma sees profit and revenue spike amid ongoing uncertainty Pharma Alliance Pharma has hailed its strong second half performance for helping it to record sales and additional profit expansion in its preliminary results despite the healthcare group having delayed its audited results three times this year.